Paradoxical reactions of benzodiazepines ― a genetically determined phenomenon?SHORT, T. G; FORREST, P; GALLETLY, D. C et al.Anaesthesia and intensive care. 1987, Vol 15, Num 3, pp 330-331, issn 0310-057XArticle

Abstracts of presented papers/Anticancer drugs: therapeutic index improvement by toxicity reduction, international conference, London, UK, 6-7 April 1987Anti-cancer drug design. 1987, Vol 2, Num 1, pp 89-101, issn 0266-9536Conference Proceedings

Correlations between leukocyte count and absolute granulocyte count in patients receiving cancer chemotherapyBENSON, A. L. III; READ, T. R. C; GOEBEL, S. L et al.Cancer. 1985, Vol 56, Num 6, pp 1350-1355, issn 0008-543XArticle

The effect of etoposide on human CFU-GMBAILEY-WOOD, R; DALLIMORE, C. M; LITTLEWOOD, T. J et al.British journal of cancer. 1985, Vol 52, Num 4, pp 613-617, issn 0007-0920Article

Correlation of tumour-inhibiting activity with acute toxicityBRADBURNE, S. J. A; DEARDEN, J. C.Science of the total environment. 1991, Vol 109-110, pp 425-429, issn 0048-9697Conference Paper

Methylation of DNA by incubation with methylamine and nitrite = Méthylation du DNA par incubation avec la méthylamine et nitriteHUBER, K. W; LUTZ, W. K.Carcinogenesis (New York. Print). 1984, Vol 5, Num 3, pp 403-406, issn 0143-3334Article

Optimale Konzentration von Dexamethason in Externa = Concentration optimale de dexaméthasone dans les topiques = Optimal concentration of dexamethasone in topicsSTÜTTGEN, G.Hautarzt. 1984, Vol 35, Num 8, issn 0017-8470, 433Article

Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatinTAKAHASHI, K; SEKI, T; NISHIKAWA, K et al.Gann. 1985, Vol 76, Num 1, pp 68-74, issn 0016-450XArticle

Conformation-activity relationships in polyketide natural products: A new perspective on the rational design of epothilone analoguesTAYLOR, Richard E; YUE CHEN; BEATTY, Alicia et al.Journal of the American Chemical Society. 2003, Vol 125, Num 1, pp 26-27, issn 0002-7863, 2 p.Article

Regional doxorubicin delivery reduces testicular toxicityLUI, R. C; LAREGINA, M. C; HERBOLD, D. R et al.The Journal of surgical research. 1987, Vol 43, Num 3, pp 286-295, issn 0022-4804Article

Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agentYU, P. H.Research communications in chemical pathology and pharmacology. 1986, Vol 51, Num 2, pp 163-171, issn 0034-5164Article

Antitumor effects of immobilized protein A and staphylococcal products: linkage between toxicity and efficacy, and identification of potential tumoricidal reagentsTERMAN, D. S; BERTRAM, J. H.European journal of cancer & clinical oncology. 1985, Vol 21, Num 10, pp 1115-1122, issn 0277-5379Article

Octanol-water partition coefficient of benzo(a)pyrene: measurement, calculation, and environmental implicationsMALLON, B. J; HARRISON, F. L.Bulletin of environmental contamination and toxicology. 1984, Vol 32, Num 3, pp 316-323, issn 0007-4861Article

Bleomycin-induced DNA cleavage: studies in vitro and in intact cellsMOSELEY, P. L; CHALKLEY, R.The Journal of laboratory and clinical medicine. 1987, Vol 110, Num 5, pp 618-623, issn 0022-2143Article

Theoretically required urinary flow during high-dose methotrexate infusionSASAKI, K; TANAKA, J; FUJIMOTO, T et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 1, pp 9-13, issn 0344-5704Article

A study of perforin appearing in human lymphokine-activated killer (LAK) cells derived from spleen and peripheral blood mononuclear cellsKATAOKA, K.Nippon Geka Gakkai Zasshi. 1992, Vol 93, Num 4, pp 352-362, issn 0301-4894Article

Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?RODVOLD, K. A; ZOKUFA, H; ROTSCHAFER, J. C et al.Clinical pharmacy. 1988, Vol 7, Num 8, pp 608-613, issn 0278-2677Article

Effects of multiple putative anticarcinogens on the carcinogenicity of trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxodiazoleDUNSFORD, H. A; DOLAN, P. M; SEED, J. L et al.Journal of the National Cancer Institute. 1984, Vol 73, Num 1, pp 161-168, issn 0027-8874Article

Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazidPERETTI, E; KARLAGANIS, G; LAUTERBURG, B. H et al.European journal of clinical pharmacology. 1987, Vol 33, Num 3, pp 283-286, issn 0031-6970Article

Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicityROTMENSCH, H. H; BELHASSEN, B; SWANSON, B. N et al.Annals of internal medicine. 1984, Vol 101, Num 4, pp 462-468, issn 0003-4819Article

Évaluation des médicaments après leur commercialisation = Post-market assessment of drugsEL HASNAOUI, A; BAIL, J. N.La Lettre du pneumologue. 2004, Vol 7, Num 3, pp 121-124, issn 1292-5977, 4 p.Article

The plight of the cancer patient: the double-edged sword = La condition de malade cancéreux: l'épée à double tranchantSOLOWAY, M. S.The Journal of urology. 1983, Vol 130, Num 2, issn 0022-5347, 349Article

Fluorescent profiling of natural product producersSANDLER, Joel S; FENICAL, William; GULLEDGE, Brian M et al.Journal of the American Chemical Society. 2005, Vol 127, Num 26, pp 9320-9321, issn 0002-7863, 2 p.Article

Thalidomide use in pediatric patientsBESSMERTNY, Olga; PHAM, Trinh.The Annals of pharmacotherapy. 2002, Vol 36, Num 3, pp 521-525, issn 1060-0280Article

Adverse drug reactions of DMARDs and DC-ARTs in rheumatoid arthritisWOLFE, F.Clinical and experimental rheumatology (Testo stampato). 1997, Vol 15, pp S75-S81, issn 0392-856X, SUP17Article